Please Click Here to Download the 2019 CME Packet


Cutting Edge of Transplantation 

February 21-23, 2019

Arizona Biltmore - Phoenix, AZ


Target Audience

The educational design of this activity addresses the needs of healthcare professionals (physicians, surgeons, pharmacists, nurses, and others) and researchers working in the field of transplantation.

Statement of Need/Program Overview

CEoT 2019 will focus on personalizing decision making and individualizing pathways of care throughout the transplant journey.  Currently most transplant care utilizes a “one size fits all” approach.  Attempts to individualize care are largely based on empirical data or gestalt.  CEoT 2019 will bring together a diverse group of transplant professionals representing the interests and perspectives of clinicians, investigators, the FDA, UNOS, the SRTR, AOPO, and insurers.  The overarching goal is to consider evidence-based strategies to introduce algorithms or practices to facilitate personalized care in all aspects of transplant decision making spanning the processes of evaluation for transplantation, preparation for transplantation, decisions about organ acceptance, immunosuppressive management, and post-transplant immune monitoring. 

Educational Objective

The following overarching objectives and more specific goals have been identified for this meeting. Having participated in this meeting, attendees will be able to:

Ÿ Describe how other medical fields such as hematology and cardiology have developed technologies and biomarkers to facilitate personalized care.

Ÿ Describe interventions to optimize the candidacy of individuals with organ failure who present challenges to successful transplantation such as obesity, malnutrition, frailty, or lack of a social support system.

Ÿ Describe the challenges and potential strategies to match donated organs to appropriate recipients without disadvantaging the individual or increasing the number of discarded organs.

Ÿ Describe the evolving landscape of transplant diagnostics to detect alloimmune mediated graft injury including the intended use of these diagnostics to detect rejection, predict rejection, or allow minimization of immunosuppression following transplantation.

Ÿ Describe how in the future the development of validated biomarkers may be used to guide the selection of optimized immunosuppressive regimens for individuals of differing clinical or molecular phenotypes.

Ÿ Describe how minimizing HLA/epitope mismatching combined with assays to more fully characterize humoral and cellular immunity may lead to risk stratification of individual recipients and personalized care plans.


Continuing Education Credit

This activity is jointly provided by Global Education Group and American Society of Transplantation.



This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and American Society of Transplantation. Global is accredited by the ACCME to provide continuing medical education for physicians. 

Global Education Group designates this live activity for up to 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Global Education Group designates this continuing education activity for up to 16.25 contact hour(s) (16.25 CEUs) of the Accreditation Council for Pharmacy Education. Each approved session will have its own UAN identification number (UANs pending).

This is a knowledge-based activity.


Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for up to 16.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or CME@globaleducationgroup.com.

How to Claim Credit

Following the meeting, attendees must complete an online evaluation form in order to request a certificate for any of the types of credit listed above, or for a general certificate of attendance. 

Fee Information & Refund/Cancellation Policy

Registration Type Early Bird Fees Fees After January 1st, 2019
Doctoral Member $340 $350
Non-Doctoral Member $210 $220
Trainee Member $195 $205
Doctoral Non-Member $895 $925
Non-Doctoral Non-Member $260 $270
Trainee Non-Member $335 $345
Industry $895 $925


*To cancel your registration, a written request must be received in the AST office by January 23, 2019. Cancellation requests received by this date will be refunded less a $50 processing fee per person. Requests will be processed after the meeting. There will be no refunds issued for requests received on or after the above date.


Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. An information packet will be available that contains the faculty conflict of interest disclosures and other important information.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and American Society of Transplantation do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.    


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.